CMS said it was no longer considering a "stacking" proposal for Medicaid drug pricing calculations, which could have increased 340B savings.
CMS Drops ‘Stacking’ Proposal Which Could Have Boosted 340B Savings
Federal regulators said they were dropping from consideration a proposal for “stacking” discounts as part of an update to Medicaid [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.